LncRNA CAHM, lncRNA DUXAP8, lncRNA SNHG1, and lncRNA KIF9–AS1 provide new ideas for improving treatment resistance in patients with HCC. This evidence concerns the gene DUXAP8 and hepatocellular carcinoma.